| Literature DB >> 27908451 |
Eduardo Anitua1, Roberto Prado2, Gorka Orive3.
Abstract
A new therapeutic tool is emerging based on a biomimetic strategy: platelet-rich plasma (PRP) technology. Allogeneic off-the-shelf PRP represents a safe and cost-effective treatment for osteoarthritis and related diseases. This breakthrough opens the door not only to improved treatments and opportunities but also to new challenges with multiple uncertainties.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27908451 DOI: 10.1016/j.tibtech.2016.11.001
Source DB: PubMed Journal: Trends Biotechnol ISSN: 0167-7799 Impact factor: 19.536